Dendreon and its fall from grace over the past few months has no real bearing on PRR and it's SP
Remember Dendreon got FDA approval for Provenge over a year ago and it is being clinicaly used throught the US for prostate care
It has met with some costing problems etc and that is the reason for its share value falling some 70 odd percent from a high around US$50
PRR of course is still a long way from FDA approval,2 years plus,if it happens, and I am confident that it will, that is why I am invested
PRR has no revenues coming in at present but hopefully that is set to change when the Dubai Hospital starts administering Cvac, around the New year it seems
If all goes well in Dubai and the World Health Council start to recognise that Cvac is giving prolonged life spans to the women of the Middle East suffering from Ovarian cancer, then there is a bright outlook for Prima Biomed
DYOR
Keep the faith
- Forums
- ASX - By Stock
- nasdq
Dendreon and its fall from grace over the past few months has no...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
34.0¢ |
Change
-0.005(1.45%) |
Mkt cap ! $493.8M |
Open | High | Low | Value | Volume |
34.0¢ | 34.0¢ | 32.5¢ | $1.317M | 3.935M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 73996 | 33.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.0¢ | 836970 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 67679 | 0.325 |
11 | 193888 | 0.320 |
1 | 25000 | 0.315 |
2 | 35400 | 0.310 |
5 | 103336 | 0.305 |
Price($) | Vol. | No. |
---|---|---|
0.340 | 674262 | 1 |
0.345 | 179754 | 4 |
0.350 | 527571 | 5 |
0.355 | 30000 | 1 |
0.360 | 51000 | 2 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |